Hypomorphic pathogenic variant in SFTPB leads to adult pulmonary fibrosis.
Tifenn DesroziersGrégoire PrévotAurore CoulombValérie NauFlorence Dastot-Le MoalPhilippe DuquesnoyMélanie HéryAurélie Le BorgneSerge AmselemMarie LegendreNadia NathanPublished in: European journal of human genetics : EJHG (2023)
Biallelic pathogenic variants in the surfactant protein (SP)-B gene (SFTPB) have been associated with fatal forms of interstitial lung diseases (ILD) in newborns and exceptional survival in young children. We herein report the cases of two related adults with pulmonary fibrosis due to a new homozygous SFTPB pathogenic variant, c.582G>A p.(Gln194=). In vitro transcript studies showed that this SFTPB synonymous pathogenic variant induces aberrant splicing leading to three abnormal transcripts with the preservation of the expression of a small proportion of normal SFTPB transcripts. Immunostainings on lung biopsies of the proband showed an almost complete loss of SP-B expression. This hypomorphic splice variant has thus probably allowed the patients' survival to adulthood while inducing an epithelial cell dysfunction leading to ILD. Altogether, this report shows that SFTPB pathogenic variants should be considered in atypical presentations and/or early-onset forms of ILD particularly when a family history is identified.
Keyphrases
- pulmonary fibrosis
- early onset
- interstitial lung disease
- poor prognosis
- copy number
- end stage renal disease
- late onset
- newly diagnosed
- ejection fraction
- chronic kidney disease
- pregnant women
- oxidative stress
- rheumatoid arthritis
- peritoneal dialysis
- prognostic factors
- idiopathic pulmonary fibrosis
- free survival
- dna methylation
- patient reported outcomes
- low birth weight
- early life
- cord blood
- single cell
- gestational age
- preterm infants
- patient reported